Upfront allogeneic hematopoietic cell transplantation (HCT) versus remission induction chemotherapy followed by allogeneic HCT for acute myeloid leukemia with multilineage dysplasia: A propensity score matched analysis

Author:

Konuma Takaaki1,Harada Kaito2ORCID,Yamasaki Satoshi3,Mizuno Shohei4,Uchida Naoyuki5,Takahashi Satoshi6,Onizuka Makoto2,Nakamae Hirohisa7,Hidaka Michihiro8,Fukuda Takahiro9,Ohashi Kazuteru10,Kohno Akio11,Matsushita Akiko12,Kanamori Heiwa13,Ashida Takashi14,Kanda Junya15,Atsuta Yoshiko1617,Yano Shingo18,

Affiliation:

1. Department of Hematology/Oncology; The Institute of Medical Science, The University of Tokyo; Tokyo Japan

2. Department of Hematology and Oncology; Tokai University School of Medicine; Isehara Japan

3. Department of Hematology and Clinical Research Institute; National Hospital Organization Kyushu Medical Center; Fukuoka Japan

4. Division of Hematology, Department of Internal Medicine; School of Medicine, Aichi Medical University; Nagakute Japan

5. Department of Hematology; Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital; Tokyo Japan

6. Division of Molecular Therapy, The Advanced Clinical Research Center; The Institute of Medical Science, The University of Tokyo; Tokyo Japan

7. Hematology; Graduate School of Medicine, Osaka City University; Osaka Japan

8. Department of Hematology; National Hospital Organization Kumamoto Medical Center; Kumamoto Japan

9. Department of Hematopoietic Stem Cell Transplantation; National Cancer Centre Hospital; Tokyo Japan

10. Hematology Division; Tokyo Metropolitan Cancer and Infectious Diseases Centre; Tokyo Japan

11. Department of Hematology and Oncology; JA Aichi Konan Kosei Hospital; Konan Japan

12. Department of Hematology; Kobe City Hospital Organization Kobe City Medical Center General Hospital; Kobe Japan

13. Department of Hematology; Kanagawa Cancer Center; Kanagawa Japan

14. Department of Hematology and Rheumatology; Faculty of Medicine, Kindai University; Osaka Japan

15. Department of Hematology and Oncology; Graduate School of Medicine, Kyoto University; Kyoto Japan

16. Japanese Data Center for Hematopoietic Cell Transplantation; Nagoya Japan

17. Department of Healthcare Administration; Nagoya University Graduate School of Medicine; Nagoya Japan

18. Division of Clinical Oncology and Hematology, Department of Internal Medicine; The Jikei University School of Medicine; Tokyo Japan

Funder

Japan Agency for Medical Research and Development, AMED

Publisher

Wiley

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3